Clinical trial NCT00578162: A Study of Survivorship Service Capacities Among Health Care Agencies in New York City
Official title: A Study of Survivorship Service Capacities Among Health Care Agencies in New York City
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: All Cancers
Keywords: Cancer
Survivors
Lead sponsor: Memorial Sloan Kettering Cancer Center
Sponsor class: OTHER
Collaborators: name: NYS DEPT HEALTH CANCER SVC PRO
First posted: 2007-12-21
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: We assume that the collective network of cancer care and support services can be represented with data from no more than 300 New York City agencies, across all five boroughs. Theseagencies would include hospitals, clinical diagnostic centers, and community-based organizations.

Brief summary: To describe the range of services available to cancer survivors in the NYC area.

To determine organizations' need for assistance to enhance services for survivors.

Detailed description: To describe the range of services available to cancer survivors in the NYC area.

To determine organizations' need for assistance to enhance services for survivors.

Eligibility criteria: Inclusion Criteria:

* To be eligible to participate in the study, an agency must:

  1. Be a current provider of either:

     * General health services (GHS), such as primary care, health education and wellness, mental health services, home health care, palliative care, or cancer screening and diagnosis;
     * Cancer-specific medical treatments (CMT), such as cancer surgery, radiation, chemotherapy, hormonal therapy; experimental therapies; cancer pain and symptom management; rehabilitation services; post-treatment monitoring and surveillance; or prophylactic treatments, such as chemoprevention; or
     * Any type of specialized 'post-cancer' or 'after-cancer' medical care or support services (SMC) (i.e., psychotherapeutic, relationship and family, psycho-educational,wellness and quality of life)
  2. Be located within the five boroughs of New York City
  3. Have been serving cancer patients for 12 months or longer, and
  4. Be willing and able to identify an English-speaking representative, 21 years of age or older as its designated key informant.

Exclusion Criteria:

* We will limit this study to provider agencies such as hospitals, diagnostic centers, clinics, health and human service agencies, and grassroots community organizations and public service settings that offer programs for cancer survivors. Independent practitioners or private practice settings will not be surveyed. Our survey questions are intended for major health services organizations and are not appropriate for private practices settings.

We will use our screening questionnaire to determine where or not a given agency should be included or excluded from the study AGENCY SCREENER.

Primary outcomes:
measure: To determine agencies' need for assistance to enhance services for survivors.
timeFrame: 2 years
Secondary outcomes:
Other outcomes:
Locations:
city: New York
country: United States
facility: Memorial Sloan-Kettering Cancer Center
state: New York
Study officials:
affiliation: Memorial Sloan Kettering Cancer Center
name: David Loundsbury, PhD
role: PRINCIPAL_INVESTIGATOR
References: